AIM IMMUNOTECH (Germany) Today
| HXB2 Stock | EUR 0.36 0.01 2.86% |
Performance4 of 100
| Odds Of DistressLess than 19
|
AIM IMMUNOTECH is trading at 0.36 as of the 25th of April 2024. This is a 2.86 percent up since the beginning of the trading day. The stock's lowest day price was 0.36. AIM IMMUNOTECH has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for AIM IMMUNOTECH INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2022 and ending today, the 25th of April 2024. Click here to learn more.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viruses, and immune-deficiency disorders in the United States. AIM ImmunoTech Inc. was incorporated in 1990 and is headquartered in Ocala, Florida. The company has 48.08 M outstanding shares. More on AIM IMMUNOTECH INC
Moving against AIM Stock
| 0.65 | TCID | Telkom Indonesia Tbk | PairCorr |
| 0.47 | VX1 | Vertex Pharmaceuticals | PairCorr |
| 0.47 | NVPJ | TMBThanachart Bank Public | PairCorr |
| 0.45 | E908 | Lyxor 1 | PairCorr |
| 0.42 | DBPD | Xtrackers ShortDAX | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AIM Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AIM IMMUNOTECH's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AIM IMMUNOTECH or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Thomas Equels |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
AIM IMMUNOTECH INC (HXB2) is traded on Frankfurt Exchange in Germany and employs 21 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AIM IMMUNOTECH's market, we take the total number of its shares issued and multiply it by AIM IMMUNOTECH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AIM IMMUNOTECH INC operates under Healthcare sector and is part of Biotechnology industry. The entity has 48.08 M outstanding shares.
AIM IMMUNOTECH INC has accumulated about 41.14 M in cash with (10.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check AIM IMMUNOTECH Probability Of Bankruptcy
Ownership AllocationAIM IMMUNOTECH INC retains a total of 48.08 Million outstanding shares. Almost 86.0 percent of AIM IMMUNOTECH outstanding shares are held by general public with 1.3 (percent) owned by insiders and only 12.27 % by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check AIM Ownership Details
AIM Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of AIM IMMUNOTECH jumping above the current price in 90 days from now is about 50.0%. The AIM IMMUNOTECH INC probability density function shows the probability of AIM IMMUNOTECH stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon AIM IMMUNOTECH INC has a beta of -0.0253. This usually indicates as returns on the benchmark increase, returns on holding AIM IMMUNOTECH are expected to decrease at a much lower rate. During a bear market, however, AIM IMMUNOTECH INC is likely to outperform the market. Additionally, aIM IMMUNOTECH INC has an alpha of 0.4201, implying that it can generate a 0.42 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of AIM IMMUNOTECH to move above the current price in 90 days from now is about 50.0 (This AIM IMMUNOTECH INC probability density function shows the probability of AIM Stock to fall within a particular range of prices over 90 days) .
AIM IMMUNOTECH INC Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. AIM IMMUNOTECH market risk premium is the additional return an investor will receive from holding AIM IMMUNOTECH long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AIM IMMUNOTECH. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although AIM IMMUNOTECH's alpha and beta are two of the key measurements used to evaluate AIM IMMUNOTECH's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 6.07 | |||
| Semi Deviation | 6.91 | |||
| Standard Deviation | 9.64 | |||
| Variance | 92.96 |
AIM Stock Against Markets
Picking the right benchmark for AIM IMMUNOTECH stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AIM IMMUNOTECH stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AIM IMMUNOTECH is critical whether you are bullish or bearish towards AIM IMMUNOTECH INC at a given time. Please also check how AIM IMMUNOTECH's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in AIM IMMUNOTECH without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
AIM IMMUNOTECH Corporate Management
Elected by the shareholders, the AIM IMMUNOTECH's board of directors comprises two types of representatives: AIM IMMUNOTECH inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AIM. The board's role is to monitor AIM IMMUNOTECH's management team and ensure that shareholders' interests are well served. AIM IMMUNOTECH's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AIM IMMUNOTECH's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wayne Springate | Senior Vice President - Operations | Profile | |
| Stewart Appelrouth | Director | Profile | |
| David Strayer | Chief Scientific & Medical Officer | Profile | |
| William Mitchell | Chairman of the Board | Profile |
How to buy AIM Stock?
Before investing in AIM IMMUNOTECH, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AIM IMMUNOTECH. To buy AIM IMMUNOTECH stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of AIM IMMUNOTECH. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase AIM IMMUNOTECH stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located AIM IMMUNOTECH INC stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased AIM IMMUNOTECH INC stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AIM IMMUNOTECH INC, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in AIM IMMUNOTECH INC?
The danger of trading AIM IMMUNOTECH INC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AIM IMMUNOTECH is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AIM IMMUNOTECH. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AIM IMMUNOTECH INC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in AIM IMMUNOTECH INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in AIM Stock please use our How to Invest in AIM IMMUNOTECH guide.Note that the AIM IMMUNOTECH INC information on this page should be used as a complementary analysis to other AIM IMMUNOTECH's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for AIM Stock analysis
When running AIM IMMUNOTECH's price analysis, check to measure AIM IMMUNOTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM IMMUNOTECH is operating at the current time. Most of AIM IMMUNOTECH's value examination focuses on studying past and present price action to predict the probability of AIM IMMUNOTECH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM IMMUNOTECH's price. Additionally, you may evaluate how the addition of AIM IMMUNOTECH to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |